Acotec Scientific Holdings Ltd
Company Profile
Business description
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions.
Contact
16 North Hongda Road
4-5th Floor, Building No. 1
Beijing Economic-Technological Development Area
Beijing
CHNT: +86 1067872107
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
650
Stocks News & Analysis
stocks
A collection of our best stock opportunities
stocks
Morningstar analyst reacts to Macquarie Group’s earnings
stocks
Undervalued ASX share showing progress in global efforts
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,963.50 | 29.20 | 0.33% |
CAC 40 | 7,849.62 | 15.04 | 0.19% |
DAX 40 | 24,202.27 | 15.23 | -0.06% |
Dow JONES (US) | 44,901.92 | 208.01 | 0.47% |
FTSE 100 | 9,103.12 | 17.19 | -0.19% |
HKSE | 25,562.13 | 173.78 | 0.68% |
NASDAQ | 21,108.32 | 50.36 | 0.24% |
Nikkei 225 | 40,998.27 | 457.96 | -1.10% |
NZX 50 Index | 12,910.74 | 57.28 | 0.45% |
S&P 500 | 6,388.64 | 25.29 | 0.40% |
S&P/ASX 200 | 8,697.70 | 30.80 | 0.36% |
SSE Composite Index | 3,597.94 | 4.28 | 0.12% |